Orkla India Approves Grant of 11.12 Lakh ESOPs Under ESOP Plan 2025
Orkla India Ltd · Others (Uncategorized) · 06 Nov 2026, 4:21 pm
Orkla India Approves Grant of 11.12 Lakh ESOPs Under ESOP Plan 2025 Orkla India Limited's Nomination and Remuneration Committee approved the grant of 11,11,850 employee stock options under its ESOP Plan 2025 on 5th Nov'26. Each option is convertible into one fully paid-up equity share at an exercise price of ₹702.90 per share, determined based on the NSE closing price of ₹528.10 on 4th Nov'26. The options carry a fixed vesting period of three years from the grant date, and vested options must be exercised within two years from the respective vesting date during employment.
Original exchange filing (PDF)
More announcements from Orkla India Ltd
- The Nomination and Remuneration Committee has approved the allotment of 10,757 equity shares to eligible employees upon exercise of vested options · 18 Nov 2026
- Q2 FY 27 Earnings Conference Call Transcript · 11 Nov 2026
- Audio Recording of Q2 FY 2026-27 Earnings Call · 05 Nov 2026
- Press Release on Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026 · 04 Nov 2026
- Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Investor Presentation on Financial Results for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Outcome of Board Meeting held on November 04, 2026 to consider Financial Results for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Orkla India Limited has submitted to the Exchange, the unaudited standalone and consolidated financial results for the period ended September 30, 2026. · 04 Nov 2026
